Marked chromogranin A elevation in a patient with bilateral adrenal incidentalomas, and its rapid normalization after discontinuation of proton pump inhibitor therapy.
Igaz
Peter
P
Müllner
Katalin
K
Hargitai
Beáta
B
Igaz
Ivan
I
Tömböl
Zsófia
Z
Rácz
Károly
K
Tulassay
Zsolt
Z
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000009:adverse effects*; D000310:Adrenal Gland Neoplasms / Q000097:blood / Q000000981:diagnostic imaging*; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D053379:Chromogranin A / Q000097:blood*; D003937:Diagnosis, Differential; D003951:Diagnostic Errors; D005260:Female; D006801:Humans; D064747:Lansoprazole; D010673:Pheochromocytoma / Q000097:blood / Q000000981:diagnostic imaging*; D054328:Proton Pump Inhibitors / Q000009:adverse effects*; D014463:Ultrasonography
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D014408:Biomarkers, Tumor; D053379:Chromogranin A; D054328:Proton Pump Inhibitors; D064747:Lansoprazole